Verve Therapeutics Stock Price on November 12, 2024
| VERV Stock | USD 6.02 0.28 4.44% |
If you're considering investing in Verve Stock, it is important to understand the factors that can impact its price. As of today, the current price of Verve Therapeutics stands at 6.02, as last reported on the 29th of December, with the highest price reaching 6.53 and the lowest price hitting 5.92 during the day. Verve Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Verve Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0837, which indicates the firm had a 0.0837% return per unit of risk over the last 3 months. By inspecting Verve Therapeutics' technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please review Verve Therapeutics' Risk Adjusted Performance of 0.0772, semi deviation of 4.72, and Coefficient Of Variation of 1164.31 to confirm if our risk estimates are consistent with your expectations.
Verve Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Verve |
Sharpe Ratio = 0.0837
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VERV | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.33 actual daily | 56 56% of assets are less volatile |
Expected Return
| 0.53 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Verve Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Verve Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.0022 | Enterprise Value Ebitda (0.40) | Price Sales 20.8918 | Shares Float 62.4 M | Wall Street Target Price 26.2022 |
Related Headline
Beam Therapeutics Headline on 12th of November 2024
Acquisition by Walsh Kathleen E of 16532 shares of Beam Ther... by Walsh Kathleen E
Filed transaction by Beam Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Verve Therapeutics Valuation on November 12, 2024
It is possible to determine the worth of Verve Therapeutics on a given historical date. On November 12, 2024 Verve was worth 6.33 at the beginning of the trading date compared to the closed value of 6.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Verve Therapeutics stock. Still, in general, we apply an absolute valuation method to find Verve Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Verve Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Verve Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 6.43 | 6.75 | 6.26 | 6.42 | 5,334,885 | |
11/12/2024 | 6.33 | 6.50 | 6.21 | 6.41 | 1,241,197 |
| 6.51 | 6.68 | 5.78 | 5.79 | 1,194,001 |
| Backtest Verve Therapeutics | | | Verve Therapeutics History | | | Verve Therapeutics Valuation | Previous | Next |
Verve Therapeutics Trading Date Momentum on November 12, 2024
| On November 13 2024 Verve Therapeutics was traded for 5.79 at the closing time. The top price for the day was 6.68 and the lowest listed price was 5.78 . The trading volume for the day was 1.2 M. The trading history from November 13, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 9.67% . The trading price change against the current closing price is 29.80% . |
Verve Therapeutics Fundamentals Correlations and Trends
By evaluating Verve Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Verve Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Verve financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Verve Therapeutics Stock history
Verve Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Verve is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Verve Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Verve Therapeutics stock prices may prove useful in developing a viable investing in Verve Therapeutics
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Verve Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 113 people.
Verve Therapeutics Quarterly Net Working Capital |
|
Verve Therapeutics Stock Technical Analysis
Verve Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Verve Therapeutics Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Verve Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Verve Therapeutics December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Verve Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verve Therapeutics shares will generate the highest return on investment. By undertsting and applying Verve Therapeutics stock market strength indicators, traders can identify Verve Therapeutics entry and exit signals to maximize returns
Verve Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Verve Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Verve Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Verve to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0772 | |||
| Jensen Alpha | 0.5106 | |||
| Total Risk Alpha | 0.3532 | |||
| Sortino Ratio | 0.0965 | |||
| Treynor Ratio | 0.6957 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Verve Stock Analysis
When running Verve Therapeutics' price analysis, check to measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.